Randomized Clinical Trials Comparing Initial Therapies for Glaucoma.
International ophthalmology clinics（2023）
Abstract
E.C.B. has served as an advisor for Santen, Inc., and has received financial support from CorneaGen Inc. J.F.P. has been a consultant/advisor for Aerie Pharmaceuticals, Allergan, Glaukos, New World Medical, and Santen, Inc., and has received grant support from CorneaGen Inc.
MoreTranslated text
Key words
glaucoma,clinical trials,initial therapies,randomized
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined